Scientists search for clues in blood and skin to predict melanoma treatment success
NCT ID NCT03225365
Summary
This study aimed to understand how the immune system changes in people with advanced melanoma who receive immunotherapy drugs (nivolumab with or without ipilimumab). Researchers collected blood samples and skin biopsies from 5 patients to closely examine their immune cells. The goal was to identify differences between patients who responded well to treatment and those who did not, to help predict outcomes in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
Pierre-Bénite, 69310, France
Conditions
Explore the condition pages connected to this study.